Industry News
Medical Device Industry News
How to Deal with the Loss of a Loved One: Coping Strategies
This article shares some coping strategies for dealing with a loved one's passing. Continue reading to learn more.
Enterprise Therapeutics Publishes on Medicinal Chemistry of ETD001 | A Novel Inhaled ENaC Blocker for Treatment of Cystic Fibrosis
The paper describes the medicinal chemistry optimisation of a new series of ENaC blockers, resulting in the invention of ETD001, Enterprise’s lead asset, a potential new inhaled treatment for cystic fibrosis notes Enterprise Therapeutics.
Cytomos Secures £5M | To Scale Up Production of Cell-analysis Technology
New investment will allow Cytomos to drive sales of its first commercial product, Celledonia™, built on its cell-analysis technology platform AuraCyt, which is already generating significant market traction.
TactoTek Secures $60 Million in Funding Led by Virala Group
With this funding, TactoTek will accelerate the adoption of IMSE globally by expanding customer-facing operations and streamlining IMSE solution design by augmenting our software-based delivery system with AI elements and plug-ins for CAD and simulation
The Future of Precision Medicine Delivering ROI for the Healthcare Industry | By: Gary Turner, Managing Director, Additive Manufacturing, Ricoh USA, Inc.
Gary Turner asks: What do orthopedic surgery and additive manufacturing have in common? 3D surgical guides. This experts shares his views.
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial (“INVINCIBLE-3 Study”) in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS)
Phase 1/2 data showed a median overall survival (“mOS”) of 21.3 months versus a synthetic control of 6.7 months, an increase in T-cell activation, and favorable safety profile for patients receiving INT230-6 alone notes Intensity
Boston Scientific Closes Acquisition of Axonics
Meghan Scanlon, senior vice president and president, Urology, Boston Scientific. “By closing this acquisition, we’re pleased to welcome the Axonics team into Boston Scientific. The addition of the Axonics product portfolio enables us to expand
How to Choose Bags & Cases for Medical Professionals and Students
So, how can one design bags and cases for medical professionals and students? This guide will share the details you need to know.
Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with
Stryker Launches Next-Generation of SurgiCount+
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for
Real-Time Assistive Voice App Turns Whispers to Speech
Real-Time Assistive Voice App: Millions of people the world over suffer from various deficits in speech that make it difficult for them to communicate over the phone. Whether it be a stutter, damaged vocal chords
Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized
Predictive Heart Monitoring Startup, GPx, Secures NEC X Investment
“GPx’s innovative approach to heart monitoring and chronic disease management is a perfect fit for the NEC Group’s vision of leveraging advanced technology to improve quality of life,” said Shintaro Matsumoto, President and CEO of
Transforming Diabetes Care: Why CGM Hardware Must Evolve for the Type 2 Population | By Dr. Chris Dawson, Head of Biosensing at TTP
The landscape of diabetes management is transforming, as continuous glucose monitoring (CGM) devices expand beyond Type 1 diabetes and into a rapidly growing Type 2 market. Changes to regulatory approvals and insurance coverage driven by
9 Ways to Land Higher Roles in Healthcare
There are several ways to ensure speedy career advancements to achieve higher roles in healthcare. The following are some strategies to achieve this goal.
How to Choose the Best Cardiologist in Bangalore for Your Heart Health
If you experience mild or severe heart pain, it is time to visit a cardiologist. You need to choose the city’s top cardiologist for your care. Guaranteeing that you always receive excellent care and thorough treatment
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDEÒ Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
Christopher M. Owens, President and Chief Executive Officer of R3 Vascular. “Initiation of this trial will begin in Q1 2025 and will be conducted at up to 60 global clinical sites with 264 subjects, and
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Nick Spadea-Anello, global president, Electrophysiology, Boston Scientific said, "We believe the addition of the Cortex technology complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex AF cases."
Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to
Jason Whiting Appointed CEO of Avation Medical
Jason Whiting has more than 25 years of experience in the MedTech industry, driving innovation and adoption of new technologies in the implantable, capital equipment, and wearable markets.